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Abstract 
The secondary structures of peptides /325-35 (the active toxic fragment) and /3 35-25 (reverse sequence and non-toxic fragment), as 
well as of the amidated /3(25-35)-NH 2 peptide were investigated in aqueous olution and in the solid state by means of Fourier-trans- 
formed infrared spectroscopy and circular dichroism spectroscopy. The conformations of the /325-35 and /335-25 in solid state were 
identical and contained mostly /3-sheet structures. In the solid state the amidated /3(25-35)-NH 2 peptide also contained mostly /3-sheet 
structures. Freshly prepared aqueous olutions of the /325-35 (0.5-3.8 mM) contained a ~nixture of /3-sheet and random coil structures. 
Within 30-60 rain incubation at 37°C in water or in phosphate-buffered saline solution (PBS), /3 25-35 was almost fully converted to a 
/3-sheet structure. Decreasing the temperature from 37°C to 20°C decreased the rate of conversion from random coil to /3-sheet structures, 
1-2 h being required for complete conversion. In contrast /335-25 in water or in PBS buffer had mostly a random coil structure and 
remained so for 6 days. The amidated /3(25-35)-NH 2 peptide in water (2.7 mM) was also mostly random coil. However, when this 
peptide (2-2.7 mM) was dissolved in PBS (pH 7.4) or in 140 mM NaCI, a gel was formed and its conformation was mostly /3-sheet. 
Decreasing the concentration of /3(25-35)-NH 2 peptide in 140 mM NaCI aqueous olution from 2 mM to 1 mM or below favored the 
conversion from /3-sheet structures to random coil structures. The /325-35 was toxic to PC12 cells while /3 35-25 was not. The amidated 
peptide /3(25-35)-NH 2 was at least 500-fold less toxic than /325-35. Structural differences between these/3 peptides in aqueous olutions 
may explain the difference in their respective toxicities. 
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1, Introduct ion 
The major histopathological features of Alzheimer's 
disease (AD) and Down's syndrome are intraneuronal 
fibrillary tangles composed of paired helical filaments, 
extracellular neuritic plaques containing amyloid fibrils 
and amyloid laden cerebral vessels [1 ]. A major component 
Abbreviations: AD, Alzheimer disease; CD, circular dichroism; FAB- 
MS, fast atom bombardment mass spectrometry; FTIR, Fourier transform 
infrared; HPLC, high performance liquid chromatography; PBS, phos- 
phate-buffered saline solution. 
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in the core of the extracellular plaque is a 42 to 43 amino 
acid peptide denoted /3-amyloid or A4 (/3-A4) [2-4]. The 
cerebrovascular myloid plaque contains a 39 [5] or 40 [6] 
amino acid amyloid peptide. 
It is not yet decided whether/3-A4 is causally related to 
AD or represents a by-product of neuronal cell degenera- 
tion. However, the synthetic peptides /31-42, /3 1-40 or 
/31-38 have been demonstrated to be neurotoxic to mature 
differentiated neurons in culture, with /325-35 (a peptide 
identical to the 25-35 amino acid sequence of /3-A4) 
considered to be the active fragment [7]. The amino acid 
sequence of the /325-35 is: G S N K G A I I G L M [7]. 
Other reports confirmed the toxicity of /3 peptides in 
cultured neurons [8-11], whereas in vivo experiments 
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using /3 peptides [12-14] or purified amyloid cores [15] 
injected into rat [12,13,15] or monkey [14] brain, either 
showed a lack of toxicity [12,14] or a considerable neu- 
ronal loss in the hippocampus [13,15]. 
The conformation of /3 peptides and/or their aggrega- 
tion states, as well as the differences in peptide preparative 
methods, may directly or indirectly affect their biological 
activities [9,14,16], explaining the discrepancies among 
different studies. For example, synthetic /3 1-42 is neurite 
promoting in its initially solubilized state, but, after a 2-4 
day incubation period [9] becomes aggregated and neuro- 
toxic to hippocampal cultures. These results suggest a 
rational basis for the neurotoxic effects of /3 peptides and 
prompted us to investigate their conformations. 
The conformations of /3 peptides under various condi- 
tions have been studied by several groups [16-24]. Re- 
cently it was reported that /325-35 peptide exhibits a 
concentration-dependent ra dom coil to /3-sheet ransition 
and that replacement of the charged carboxy terminus by 
an NH 2 group locks the equilibrium in a random coil 
conformation [25]. We have extended these investigations 
by examining the conformations of the active toxic frag- 
ment /325-35, of the reverse amino acid sequence /335-25 
(inactive peptide fragment) and of the amidated /3(25-35)- 
NH 2 peptide, in the solid state, aqueous solution and 
phosphate-buffered saline solution (PBS). We have corre- 
lated structural differences to in vitro toxicity using a 
PC12 cell assay. Our results confirm the earlier CD data 
on the /325-35 in aqueous solution [25] which indicated 
that /325-35 contains a mixture of random coil and /3-sheet 
structures. In contrast the reverse sequence /335-25, as 
well as the amidated peptide /3(25-35)-NH 2, retain a 
random coil structure in aqueous solution. In contrast o 
the aqueous solution results, /325-35 and /335-25 in the 
solid state have almost identical structures and both con- 
tain mainly /3-sheet structures; /3(25-35)-NH2 is also 
mostly in a /3-sheet conformation. We have studied the 
toxicity of /325-35, the reverse sequence /335-25 and the 
amidated /3(25-35)-NH 2 peptide to PCI2 cells, and we 
discuss the results in relation with their respective sec- 
ondary structures. 
2. Materials and methods 
passed through a weakly basic anionic exchange column 
by eluting with 2 N acetic acid solution and then with 
water. Final peptide solutions were lyophilized. The /325- 
35 peptide with a C-terminus amide group was synthesized 
as above, except for the use of Tentagel S RAM resin for 
synthesis and a mixture of H20, CH3CN and trifluoro- 
acetic acid for HPLC. The purity of peptides assessed by 
HPLC was greater than 95%. 
2.2. Fourier transform infrared spectroscopy (FTIR) 
The FTIR spectra of /3 peptides (from 3.8 mM to 0.5 
raM) in 2H20 (Merck, Darmstadt, Germany), in 140 mM 
NaCI 2H20 solution, or in 2H20 PBS (140 mM NaCI, 2.7 
mM KCI, 8 mM Na2HP Q and 2 mM KH2PO 4, p2H 7.4 
[pH 7.0 according to [26]]) buffer were taken either at 20°C 
or at 37°C with a Nicolet 510M FTIR spectrometer. For 
solid state measurements KBr pellets (100 mg dry KBr and 
0.1 mg amyloid peptides) were prepared by using an 
hydraulic press (Carver press) and the Macro-Micro KBr 
die kit accessory made by Spectra-Tech. 128 interfero- 
grams were taken, co-added and Fourier-transformed to 
yield infrared spectra with 4 cm-~ resolution. The thick- 
ness of the thermostated CaF 2 cells were 15 #m. A 
thermocouple was placed close to the cell for monitoring 
the temperature. The infrared spectra re representative of 
at least three independent measurements. 
2.3. Circular dichroism spectroscopy (CD) 
Peptides were solubilized in deionized water at pH 
range of 5 to 5.5. The CD (circular dichroism) spectra of/3 
peptides (0.73 raM) were taken at room temperature with a 
Jobin Yvon model CD 6 spectrometer over the 185 to 300 
nm range at a scan of 5 s per 0.5 rim. Mean residue 
ellipticity is expressed in deg. cm z. drool -~. The CD 
spectrum of the solvent (water) was subtracted from the 
CD spectrum of the sample and the resulting baseline 
corrected spectrum smoothed. Quartz cells of 0.02 cm 
thickness were used. CD spectra re representative of three 
sets of independent measurements in the case of /325-35 
peptide, while two sets of independent measurements were 
made in the case of /335-25 peptide and of/3(25-35)-NH 2 
peptide. 
2.1. Peptide synthesis and purification 2.4. Cell culture and toxicity assay 
/325-35 and the reverse sequence /3 35-25 were synthe- 
sized by solid phase peptide synthesis with an ABI 430A 
peptide synthesizer, using the Wang-resin and Fmoc pro- 
tection of the amino acids. After cleavage and purification 
by reverse phase HPLC, they were characterized by amino 
acid analysis and fast atom bombardment mass spectrome- 
try (FAB-MS). The final purification of/325-35 and /335- 
25 was done via reverse phase HPLC using HeO, CH3CN 
and H3PO ~ solvent systems, then the peptide solution was 
PC I2 cells were plated in RPMI 1640 medium (Gibco) 
supplemented with 10% horse serum and 5% fetal calf 
serum at a density of 20000 cells per well in 96-well 
plates and incubated overnight. /3 peptides were diluted 
into cell culture medium from 1 mM stock solution in 
water. After 20 h exposure to peptide containing medium 
cell viability was determined using the MTT assay [27-29]. 
The same results were obtained when undifferentiated cells 
and cells differentiated by NGF treatment were used. 
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3. Results 
3.1. Infrared spectra of /325-35, /335-25 and /3(25-35)- 
NH 2 
The FTIR spectra of /325-35 and /335-25 in the solid 
state were similar (Fig. 1A and Fig. 1B). Both spectra 
showed two bands located at 1690-1696 cm -~ and at 
1629-1633 cm -~ that are characteristic of /3-sheet confor- 
mation. It is not possible from infrared spectra to differen- 
tiate the parallel and the antiparallel /3-sheet conformation 
[30]. The infrared spectrum of /3(25-35)-NH 2 peptide in 
the solid state (Fig. 1C) shows a broad band centered at 
1625 cm -1, indicating also the presence of /3-sheet struc- 
tures. The 1669 cm-1 shoulder may correspond to small 
traces of trifluoroacetic acid and/or to other types of 
secondary structures. Freshly solubilized /3 25-35 (3.8 mM) 
in 2H20 was metastable and contained a mixture of/3-sheet 
structure and random coil (broad band centered at 1646 
cm -1) that was converted fully into /3-sheet structures 
within 1-2 h at 20°C, as evidenced by the gradual appear- 
ance of the two characteristic nfrared bands located at 
1665-1659 cm -1 and 1618-1621 cm -1 (Fig. 1D). The 
temperature change from 20°C to 37°C increased the rate 
of /3-sheet formation. After 30 mn incubation at 37°C, the 
formation of /3-sheet structure was almost complete (data 
not shown). Comparisons of the positions of the character- 
istic /3-sheet infrared bands of /325-35 in solid state (Fig. 
IA) and in aqueous olution (Fig. 1D) (1696-1690 cm -1 
vs 1665-1659 cm ~ for the first band and 1633-1629 
cm -1 vs 1621-1618 cm-1 for the second band) indicated 
formation of hydrogen bonds between water molecules and 
the carbonyl groups of the peptide backbone. Once the 
conversion from random coil to /3-sheet had stabilized, the 
/325-35 conformation remained stable as mostly /3-sheet 
structures. Similar results were obtained for the /325-35 
solubilized in PBS buffer (p2H 7.4) and incubated at 37°C 
(Fig. 2A), indicating that changing the pH from 5.5 to 7.4 
did not alter the formation of/3-sheet structures in /3 25-35 
peptide. 
Freshly solubilized /335-25 peptide in PBS buffer (p2H 
7.4) at 37°C (Fig. 2B) or in 2H20 either at 20°C (Fig. 1E) 
or at 37°C (data not shown) was converted into random 
coil structure as indicated by the single broad band located 
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Fig. 1. Infrared spectra of /325-35, /335-25 and /3(25-35)-NH 2 peptides. (A) Part of the FTIR spectrum of /325-35 peptide in dry state (KBr pellet), 
indicating that his polypeptide is mostly in /3-sheet structures. (B) Part of the FTIR spectrum of reverse sequence /335-25 peptide in dry state (KBr pellet) 
which is almost identical to the FFIR spectrum shown in Fig. 1A. (C) Part of the FTIR spectrum of /3(25-35)-NH 2 peptide in dry state (KBr pellet), 
indicating that this polypeptide contains mostly /3-sheet structures. (D) Stacked plots of FTIR spectra of /325-35 peptide (3.8 raM) in 2H~O taken after 
incubation time of 10, 60 and 90 min at 20°C. (E) Stacked plots of FTIR spectra of /335-25 peptide (3.8 raM) in 2H20 taken after incubation time of 10, 
60 and 90 rain at 20°C. (F) Stacked plots of FrlR spectra of/3(25-35)-NH 2 peptide (3.8 raM) in 21-120 taken after incubation time of I0, 60 and 90 mn at 
20°C. The 1672 cm-I peak is assigned to traces of trifluoroacetic a id. 
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Fig. 2. Infrared spectra of fl25-35, fl35-25 and fl(25-35)-NH 2 peptides 
in PBS buffer. (A) Part of the FTIR spectrum of fl25-35 peptide (2.7 
mM) in PBS buffer (p:H 7.4) taken at 37°C and after two hour 
incubation. (The 1450 cm-i band belongs to residual HO2H). (B) Part of 
the FTIR spectrum of fl35-25 peptide (2.7 raM) in PBS buffer (p2H 7.4) 
taken at 37°C and after two hour incubation. (C) Part of the infrared 
spectrum of B(25-35)-NH 2 peptide (2.7 raM) in PBS buffer (p2H 7.4) 
taken at 37°C and after two hour incubation. 
at 1649-1646 cm -1 on the FTIR spectra. /335-25 in 
aqueous solution stayed in random coil and remained so 
for long incubation time, 6 days being the longest time 
checked in our experiments. 
The fl(25-35)-NH 2 peptide (3.8 mM) freshly dissolved 
in water formed a clear solution and its infrared spectrum 
(Fig. IF) presented a broad band centered at 1648 cm- l  
that was attributed to random coil structures and remained 
stable. The 1672 cm -~ peak, is assigned to traces of 
trifluoroacetic acid, since it was also observed on other 
infrared spectra of /31-42 [19]. In contrast, the /3(25-35)- 
NH 2 peptide dissolved in PBS buffer (pH 7.4) formed a 
gel and its infrared spectrum (Fig. 2C) presented a promi- 
nent broad peak at 1627-1618 cm -~ characteristic of /3- 
sheet structures. This gel solution was stable (4 h was the 
longest period investigated) as indicated by the successive 
infrared spectra that were identical to the infrared spectrum 
in Fig. 2C. 
In order to obtain more insight into the mechanism of 
gel formation, the effects of salts were investigated. The 
infrared spectra of 140 mM NaCI aqueous solution of 
/3(25-35) peptide (Fig. 3A) are similar to the infrared 
spectra obtained from samples in water (Fig, ID) or in 
PBS (Fig. 2A). Changing the peptide concentration from 2 
mM to 0.5 mM did not alter the /325-35 peptide propen- 
sity in forming /3-sheet structures. The addition of 140 
mM NaC1 in aqueous olution of /3 35-25 peptide (from 2 
mM to 0,5 mM) produced identical infrared spectra (Fig. 
3B) than those obtained from /335-25 peptide dissolved in 
water (Fig. 1E) or in PBS (Fig. 2B), indicating that the 
/335-25 peptide structure remained random coil under 
these different conditions. The effect of 140 mM NaC1 on 
the secondary structure of /3(25-35)-NH 2 peptide was 
concentration-dependent. The formation of fl-sheet struc- 
tures was favored at 2 mM /3(25-35)-NH 2 peptide concen- 
tration as indicated by the presence of 1618-1616 cm -~ 
infrared bands, while the decrease of peptide concentration 
from 2 mM to 1 mM and below promoted the formation of 
random coil structures in /3(25-35)-NH 2 peptide (Fig. 
3C). 
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Fig. 3. Infrared spectra of /325-35, fl35-25 and fl(25-35)-NH2 peptides 
in 140 mM NaCI aqueous solution. (A) Stacked plot of the FTIR spectra 
of fl25-35 peptide at different concentrations (2.0 raM, 1.0 n~M and 0.5 
raM) in 140 mM NaC1 aqueous solution taken at 20°C and after 2 hour 
incubation. (B) Stacked plots of the VITIR spectra of fl 35-25 peptide at 
different concentrations (2.0 raM, 1.0 mM and 0.5 raM) in 140 mM NaC1 
aqueous solution taken at 20°C and after 2 hour incubation. (C) Stacked 
plots of the FTIR spectra of fl(25-35)-NH~ peptide at different concen- 
trations (2.0 raM, 1.0 mM and 0.5 raM) in 140 mM NaC1 aqueous 
solution taken at 20°C and after two hour incubation. The 1672 CM-I 
band is assigned to traces of trifluoroacetic a id. 
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3.2. Circular dichroism (CD) spectra of/325-35, /335-25 
and /3(25-35)-NH e 
The CD spectra of /325-35 were also consistent with 
the FI'IR results. Fig. 4A shows the CD spectrum of 
/325-35 taken at room temperature and is a textbook 
example of the /3-sheet structure, with the conversion to 
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Fig. 4. Circular dichroism spectra of fl25-35, /3 35-25 and /3(25-35)-NH 2 
peptides. (A) CD spectrum of /325-35 peptide in water (0.73 raM, pH 
5-5.5). The inserted plot is the time dependence of the mean residue 
ellipticity measured at 195 nm, indicating that the /3-sheet structures 
remain stable over 6 days. (B) CD spectrum of /335-25 peptide in water 
(0.73 mM, pH 5-5.5). The inserted plot (same conditions as above) 
indicates that the random coil structures remain stable over 6 days. (C) 
CD spectrum of/3(25-35)-NH z peptide in water (0.73 mM). The inserted 
plot (same conditions as above) indicates that the random coil structures 
remain stable over 6 days. 
/3-sheet structure being almost complete. The inset of Fig. 
4A indicates the time dependence of the mean residue 
ellipticity taken at 195 nm. Since negative values aroLnd 
195 nm indicate random coil structures and positive values 
indicate either /3-sheet or c~-helix structures, this plot 
measures omewhat qualitatively the random coil to /3- 
sheet structural conversion. Although the c~-helix struc- 
tures may contribute to the 195 nm region, the amount of 
c~-helix structure was relatively small as evidenced by the 
weak CD absorption at 222 nm. As pointed out above, 
freshly solubilized /335-25 in 2H20 or in PBS buffer (p2H 
7.4) was converted to random coil structure as shown by 
the FTIR spectra (Fig. 1E, Fig. 2B). This result was 
confirmed by the characteristic negative band at 195 nm 
seen on the CD spectrum taken at room temperature (Fig. 
4B). The inset of Fig. 4B shows the time dependence of 
the mean residue ellipticity taken at 195 nm and indicates 
that the random coil structure of /335-25 remained stable 
in aqueous olution over the 6-day period of examination. 
The CD spectrum of /3(25-35)-NH 2 (Fig. 4C) is similar to 
the CD spectrum of the reverse sequence peptide (Fig. 
4B), suggesting that the /3(25-35)-NH 2 peptide formed 
random coil structures. The insert of Fig. 4C presents the 
time dependence of the mean residue ellipticity taken at 
195 nm and confirmed that the random coil structure of 
/3(25-35)-NH 2 stayed random coil and remained so for 6 
days. 
3.3. Chemical stabili~, of/325-35 and /335-25 in aqueous 
solution 
The /335-25 and /325-35 peptides were analysed by 
HPLC and by FAB-MS after 6 days incubation and drying. 
No detectable chemical degradation was observed uring 
this long incubation period. /335-25 and /325-35 were also 
analysed by FTIR spectroscopy after solubilization and 
drying. Their infrared spectra were identical to the FTIR 
spectra corresponding to the initial solid state powder 
samples (Fig. 1A and Fig. IB). These results demonstrate 
that the hydration induced conversion from /3-sheet o 
random coil of the /335-25 was fully reversible. After 
drying /3 35-25 was converted from a random coil confor- 
mation in aqueous olution to its /3-sheet conformation i
the solid state. Therefore chemical degradation cannot 
explain this reversible phase transition. 
3.4. Toxici~, assays of/325-35, /335-25 and fl(25-35)-NH: 
on PC12 cells 
The toxic effect of the /3-peptides was assessed on 
PC12 cells [28] using the MTT method [27]. Inhibition of 
the cellular redox activity measured in this assay is an 
early marker for/3 peptide toxicity [28,29]. Fig. 5 depicts 
the MTT readout expressed as % control (untreated cells) 
as a function of the concentration of /325-35 (triangles). 
/325-35 showed no toxic effect at 10 -9 M or lower 
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Fig. 5. Quantitative estimation fthe toxic effect of/325-35 and /335-25 
amyloid peptides on PCI2 cells. The toxicity was assessed by the mean 
of MT]7 method [27] and was expressed as% control (untreated cells). 
Squares how the concentration response of the toxic effect of /325-35 
amyloid peptide. Triangles indicate the concentration response of the 
effect of/335-25 amyloid peptide. Filled squares and triangles correspond 
to the freshly dissolved peptides while unfilled triangles and squares 
correspond to28 days incubated peptides at 37°C. 
concentrations, the half maximal effect was at about 10 -8 
M and the full effect was reached at 10 -7 M. Similar 
results were obtained with freshly dissolved peptide (closed 
triangles) and peptides incubated for up to 28 days at 37°C 
(open triangles). The maximal reduction in MTT readout 
was about 50%. This may indicate that /325-35 affects 
only part of the cellular redox systems assayed with this 
method or that some cells are resistant o the toxic effect 
of the peptide. The reverse sequence peptide, /335-25 
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Fig. 6. Quantitative estimation of the toxic effect of/325-35 and /3(25- 
35)-NH 2 amyloid peptides on PCI2 cells. The toxicity was assessed by 
the mean of MTT method [27] and was expressed as% control (untreated 
cells). Triangles indicated the concentration response ofthe toxic effect of 
/325-35 amyloid peptides. Squares show the concentration response ofthe 
effect of /3(25-35)-NH 2 amyloid peptide. 
(squares), showed no toxicity, although in some experi- 
ments a slight decrease in the MTT read-out at 10 -6 M 
was observed. Fig. 6 also shows the effect of the amidated 
peptide, /3(25-35)-NH 2 (squares), in the PC12 toxicity 
assay in comparison to /325-35 (triangles). A decrease in 
MTT reduction was observed only at the highest concen- 
tration (10 -6 M). This indicated an at least 500-fold 
reduced toxic activity compared to /325-35. Incubation of 
/3(25-35)-NH 2 for up to 21 h at 37°C did not alter its 
toxicity (data not shown). 
4. D iscuss ion  
It has been demonstrated previously that freshly pre- 
pared and aged solutions of /31-42 may have very differ- 
ent biological activity, i,e., they may be either neurotrophic 
or neurotoxic [9]. Toxicity was found to be associated with 
self aggregation of /3-peptides [31,32]. This finding im- 
plies that structural differences of these peptides are proba- 
bly related to their difference in toxicity. More precisely, 
one may assume that a /3-sheet structure of a /3 peptide in 
aqueous olution is a prerequisite for its neurotoxic activ- 
ity. This hypothesis was confirmed for different lots of 
/3 1-40 [33] and for /3 25-35 [34]. 
Our data show that the active fragment, /325-35, adopts 
a mostly /3-sheet conformation within less than two hours 
after dissolving in water at 20°C. As we have shown by 
FTIR spectroscopy, this transition occurs in water as well 
as in the presence of salts (PBS) and is more rapid at 
elevated temperature (37°C). Once formed, the /3-sheet 
structure remains stable. This is reflected in the toxicity 
observed for/3 25-35. The same toxic effect was observed 
with freshly dissolved peptides and after aging for up to 4 
weeks. With the MTT assay, we have used an early marker 
of /3 peptide toxicity which is consistent with cell injury 
but does not necessarily imply cell death. The MTT assay 
offers the advantage that it indicates toxicity of /3 peptides 
already at about 2-3  h after addition to the culture. During 
this time, the freshly dissolved peptide acquired a /3-sheet 
structure and was toxic. These results are in accordance 
with those reported by Pike et al [34]. In contrast, the 
reverse sequence peptide /335-25 was not toxic and stayed 
in a random coil conformation in aqueous solution even 
during long incubation times. This correlation of structure 
and toxicity was confirmed by amidation of the /325-35 
carboxy-terminus. The resulting peptide, /3(25-35)-NH 2, 
did not contain /3-sheet structure in water and showed a 
dramatically reduced toxic effect. 
The addition of salts (as in PBS buffer) did not affect 
the secondary structure of both /325-35 and /335-25 while 
it led to aggregation and /3-sheet formation for /3(25-35)- 
NH 2. An effect of salts has also been reported for the 
/310-42 peptide [18]. This peptide, too, became almost 
insoluble in PBS [18] while freshly prepared /325-35 and 
/335-25 peptides were soluble in our hands. Long incuba- 
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tion times, however, favored the formation of aggregates 
from /325-35. At the concentrations used in the toxicity 
assay no aggregation of/3(25-35)-NH 2 was observed when 
added to the culture medium. The decrease of /3(25-35)- 
NH 2 concentration i 140 mM NaC1 from 2 mM to 1 mM 
favored the conversion from /3-sheets to random coil 
structures. The low level of toxicity may, therefore, be 
explained by the formation of random coil structures under 
these conditions. 
Based on theoretical considerations, the hypothesis has 
been put forward that reversal of the peptide backbone 
direction may result in the mirroring of the protein struc- 
ture similar to the mirroring obtained by inversion of the 
amino acid chirality [35]. In both cases, the side chain 
positions relative to each other and their interactions are 
retained, while a perfect mirror image including the 
polypeptide backbone is only obtained after inversion of 
chirality. Contrary to expectations of this model, our data 
show that /335-25 does not mimick the structural or 
toxicological properties of /325-35. This indicates that in 
addition to side chain interaction, an interaction with the 
ends of the polypeptide backbone as well as with Lys-28 is 
important for /3-sheet formation in the case of /325-35. 
This is in agreement with the observation by us and others 
[25] that /3(25-35)-NH 2 in water does not form /3-sheets. 
The effects of ionic strength is also important since it may 
reduce the ionic interactions that appear to play a signifi- 
cant role in the case of /3(25-35)-NH 2 peptide. We pro- 
pose that addition of NaCI may screen the positive charge 
of Lys-28, decreasing repulsive force and therefore favor- 
ing the formation of aggregates in the case of /3(25-35)- 
NH 2 . On the other hand, the structural differences between 
/325-35, /335-25 and /3(25-35)-NH 2 only become appar- 
ent after incubation in aqueous olution. In solid state, all 
peptides clearly form /3-sheets, indicating that also /335-25 
and /3(25-35)-NH 2 have the ability to adopt this confor- 
mation. 
We suggest that the differences in toxicity of/3-peptides 
are related to their different secondary structures. Forma- 
tion of/3-sheets appears to be a requirement for toxicity, in 
agreement with two recent reports [33,34]. 
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